Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017, Article ID 3516234, 3 pages
https://doi.org/10.1155/2017/3516234
Case Report

Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis

New York Presbyterian Brooklyn Methodist Hospital, 506 6th Street, Brooklyn, NY 11215, USA

Correspondence should be addressed to Jagannath M. Sherigar; moc.oohay@alamsj

Received 8 March 2017; Revised 25 May 2017; Accepted 7 June 2017; Published 6 July 2017

Academic Editor: Stephen P. Peters

Copyright © 2017 Jagannath M. Sherigar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Francque, L. Vonghia, A. Ramon, and P. Michielsen, “Epidemiology and treatment of autoimmune hepatitis,” Hepatic Medicine, vol. 4, pp. 1–10, 2012. View at Google Scholar
  2. M. P. Manns, A. W. Lohse, and D. Vergani, “Autoimmune hepatitis—update 2015,” Journal of Hepatology, vol. 62, no. 1, supplement, pp. S100–S111, 2015. View at Publisher · View at Google Scholar
  3. FI. Alvarez, P. A. Berg, F. B. Bianchi et al., “International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis,” Journal of Hepatology, vol. 31, no. 5, pp. 929–938, 1999. View at Google Scholar
  4. E. M. Hennes, M. Zeniya, A. J. Czaja et al., “Simplified criteria for the diagnosis of autoimmune hepatitis,” Hepatology, vol. 48, no. 1, pp. 169–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W. R. Kessler, O. W. Cummings, G. Eckert, N. Chalasani, L. Lumeng, and P. Y. Kwo, “Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis,” Clinical Gastroenterology and Hepatology, vol. 2, no. 7, pp. 625–631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. J. Trivedi and G. M. Hirschfield, “Review article: Overlap syndromes and autoimmune liver disease,” Alimentary Pharmacology and Therapeutics, vol. 36, no. 6, pp. 517–533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. X. Wang, W. J. Jiang, Q. Miao et al., “Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: A single center experience,” Journal of Digestive Diseases, vol. 14, no. 4, pp. 175–180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Czaja, J. E. Hay, and J. Rakela, “Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis,” Mayo Clinic Proceedings, vol. 65, no. 1, pp. 23–30, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Gassert, H. Garcia, K. Tanaka, and J. F. Reinus, “Corticosteroid-responsive cryptogenic chronic hepatitis: Evidence for seronegative autoimmune hepatitis,” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2433–2437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Heringlake, A. Schütte, P. Flemming, W. Schmiegel, M. P. Manns, and H. L. Tillmann, “Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology,” Zeitschrift fur Gastroenterologie, vol. 47, no. 5, pp. 417–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Yilmaz, O. Unlu, R. Evcen, and C. Ugurluoglu, “Acute onset seronegative autoimmune hepatitis: Are simplified diagnostic criteria sufficient?” European Journal of Gastroenterology and Hepatology, vol. 28, no. 5, pp. 607-608, 2016. View at Publisher · View at Google Scholar · View at Scopus